Skip to main content

Table 3 Multivariate analysis of risk factors associated with new vertebral fractures

From: Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis

Variable

Total AS patients

AS patients without baseline VFs

 

(n = 298)

(n = 268)

 

Odds ratio

95% CI

P-value

Odds ratio

95% CI

P-value

TNF inhibitor

      

Baseline VF

12.8

3.6 to 45.3

<0.001

   

HLA-B27

      

Uveitis

      

SASSS progression

      

CRP increase

5.4

1.7 to 17.7

0.005

4.8

1.4 to 15.9

0.011

  1. AS, ankylosing spondylitis; TNF, tumor necrosis factor; SASSS, Stokes ankylosing spondylitis spine score; CRP, C-reactive protein.